Your browser doesn't support javascript.
loading
Efficacy of Combined Use of Everolimus and Second-Generation Pan-EGRF Inhibitors in KRAS Mutant Non-Small Cell Lung Cancer Cell Lines.
da Silva-Oliveira, Renato José; Gomes, Izabela Natalia Faria; da Silva, Luciane Sussuchi; Lengert, André van Helvoort; Laus, Ana Carolina; Melendez, Matias Eliseo; Munari, Carla Carolina; Cury, Fernanda de Paula; Longato, Giovanna Barbarini; Reis, Rui Manuel.
Afiliação
  • da Silva-Oliveira RJ; Oncology Research Center, Barretos Cancer Hospital, Barretos 14784-400, Brazil.
  • Gomes INF; Oncology Research Center, Barretos Cancer Hospital, Barretos 14784-400, Brazil.
  • da Silva LS; Oncology Research Center, Barretos Cancer Hospital, Barretos 14784-400, Brazil.
  • Lengert AVH; Oncology Research Center, Barretos Cancer Hospital, Barretos 14784-400, Brazil.
  • Laus AC; Oncology Research Center, Barretos Cancer Hospital, Barretos 14784-400, Brazil.
  • Melendez ME; Oncology Research Center, Barretos Cancer Hospital, Barretos 14784-400, Brazil.
  • Munari CC; Oncology Research Center, Barretos Cancer Hospital, Barretos 14784-400, Brazil.
  • Cury FP; Oncology Research Center, Barretos Cancer Hospital, Barretos 14784-400, Brazil.
  • Longato GB; Oncology Research Center, Barretos Cancer Hospital, Barretos 14784-400, Brazil.
  • Reis RM; Oncology Research Center, Barretos Cancer Hospital, Barretos 14784-400, Brazil.
Int J Mol Sci ; 23(14)2022 Jul 14.
Article em En | MEDLINE | ID: mdl-35887120

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article